| Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ... Journal of Infectious Diseases 204 (3), 340-347, 2011 | 268 | 2011 |
| Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection W Gao, K Chua, JK Davies, HJ Newton, T Seemann, PF Harrison, ... PLoS pathogens 6 (6), e1000944, 2010 | 252 | 2010 |
| Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ... Antimicrobial agents and chemotherapy 57 (4), 1654-1663, 2013 | 250 | 2013 |
| Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 194 | 2020 |
| Safety and efficacy review of doxycycline NE Holmes, PGP Charles Clinical Medicine. Therapeutics 1, CMT. S2035, 2009 | 181 | 2009 |
| Development and validation of a penicillin allergy clinical decision rule JA Trubiano, S Vogrin, KYL Chua, J Bourke, J Yun, A Douglas, CA Stone, ... JAMA Internal Medicine 180 (5), 745-752, 2020 | 180 | 2020 |
| Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G2 subclass deficiency CL Gordon, PDR Johnson, M Permezel, NE Holmes, G Gutteridge, ... Clinical infectious diseases 50 (5), 672-678, 2010 | 148 | 2010 |
| Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections NE Holmes, PDR Johnson, BP Howden Journal of clinical microbiology 50 (8), 2548-2552, 2012 | 144 | 2012 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 137 | 2021 |
| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ... Immunity 54 (5), 1066-1082. e5, 2021 | 117 | 2021 |
| The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study KYL Chua, S Vogrin, S Bury, A Douglas, NE Holmes, N Tan, NK Brusco, ... Clinical infectious diseases 73 (3), 487-496, 2021 | 112 | 2021 |
| Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond NE Holmes, SYC Tong, JS Davis, SJ van Hal Seminars in respiratory and critical care medicine 36 (01), 017-030, 2015 | 100 | 2015 |
| Vancomycin therapeutics and monitoring: a contemporary approach ML Avent, VL Vaska, BA Rogers, AC Cheng, SJ Van Hal, NE Holmes, ... Internal medicine journal 43 (2), 110-119, 2013 | 91 | 2013 |
| Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data CLH Xu, M Raval, JA Schnall, JC Kwong, NE Holmes The Pediatric Infectious Disease Journal 39 (9), e249-e256, 2020 | 85 | 2020 |
| The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study JA Trubiano, O Smibert, A Douglas, M Devchand, B Lambros, NE Holmes, ... Open forum infectious diseases 5 (12), ofy306, 2018 | 74 | 2018 |
| What's new in the treatment of serious MRSA infection? NE Holmes, BP Howden Current opinion in infectious diseases 27 (6), 471-478, 2014 | 66 | 2014 |
| Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ... Journal of clinical microbiology 52 (9), 3384-3393, 2014 | 55 | 2014 |
| Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia SG Giulieri, SL Baines, R Guerillot, T Seemann, A Gonçalves da Silva, ... Genome medicine 10, 1-17, 2018 | 52 | 2018 |
| Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial AM Copaescu, S Vogrin, F James, KYL Chua, MT Rose, J De Luca, ... JAMA internal medicine 183 (9), 944-952, 2023 | 45 | 2023 |
| Australasian Society for Infectious Diseases Clinical Research Network. Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 44 | 2020 |
